Gastroenterology
Subcutaneous Golimumab Induces and Maintains Clinical Response and Remission in Patients with Moderate-to-Severe Ulcerative Colitis
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:18:27
- More information
Informações:
Synopsis
Two studies in the January issue of Gastroenterology show that subcutaneous golimumab induces and maintains clinical response and remission in patients with moderate-to-severe ulcerative colitis; Dr. Kuemmerle speaks to Dr. Brian G. Feagan